[Abdussemee, A., Oludolapo, A., Adeyinka, A., Olusegun, F. (2018). Bacterial pattern in acute appendicitis. Ann. Afr. Surg.,15 (1), 8–13.10.4314/aas.v15i1.3]Search in Google Scholar
[Anonymous (2013). Recommendations for preoperative antimicrobial prophylaxis. Recommendations for the use of antibacterial agents in surgical prophylaxis KS/MET-43-00/2013. Children’s Clinical University Clinic, pp. 9.]Search in Google Scholar
[Anonymous (2019). Clinical breakpoints and dosing of antibiotics. European Committee on Antimicrobial susceptibility testing. http://www.eucast.org/clinical_breakpoints/ (accessed 10 December 2019).]Search in Google Scholar
[Anonymous (2019). National Center for Biotechnology Information. PubChem Database. Avibactam, CID=9835049. https://pubchem.ncbi.nlm.nih.gov/compound/Avibactam (accessed 10 December 2019).]Search in Google Scholar
[Anonymous (2019). National Center for Biotechnology Information. PubChem Database.Amikacin,CID=37768. https://pubchem.ncbi.nlm.nih.gov/compound/Amikacin (accessed 12 December 2019).]Search in Google Scholar
[Anonymous (2019). The Drugbank. Ceftazidime. https://www.drugbank.ca/drugs/DB00438 (accessed 10 December 2019).]Search in Google Scholar
[Baldwin, C. M., Lyseng-Williamson, K. A., Keam, S. J. (2008). Meropenem: A review of its use in the treatment of serious bacterial infections. Drugs, 68 (6), 803–838.10.2165/00003495-200868060-00006]Search in Google Scholar
[Bazzaz, A., Lor, D., Mahdi, N. (2018). Impact of some antibiotics on bacteria isolated from appendices in Kirkuk Province, Iraq. Adv. Biosci. Biotechnol.,9, 1–10.10.4236/abb.2018.91001]Search in Google Scholar
[Bhangu, A., Søreide, K., Di Saverio, S., Assarsson, J. H., Drake, F. T. (2015). Acute appendicitis: Modern understanding of pathogenesis, diagnosis, and management. Lancet, 386 (10000), 1278–1287.10.1016/S0140-6736(15)00275-5]Search in Google Scholar
[Chen, C. Y., Chen, Y. C., Pu, H. N., Tsai, C. H., Chen, W. T., Lin, C. H. (2012). Bacteriology of acute appendicitis and its implication for the use of prophylactic antibiotics. Surg. Infect. (Larchmt),13 (6), 383–390.10.1089/sur.2011.13523231389]Search in Google Scholar
[Drusano, G. L., Neely, M. N., Yamada, W.M., Duncanson, B., Brown, D., Maynard, M., Vicchiarelli, M., Louie, A. (2018). The combination of fosfomycin plus meropenem is synergistic for Pseudomonas aeruginosa PAO1 in a hollow-fiber infection model. Antimicrob. Agents Chemother.,62 (12), e01682-18.10.1128/AAC.01682-18625676630249700]Search in Google Scholar
[Du, S.-J., Kuo, Cheng, C. H., Fei, A., Wei, H.-W., Chang, S.-K. (2010). Molecular mechanisms of ceftazidime resistance in Pseudomonas aeruginosa isolates from canine and human infections. Original Paper Veterin. Med.55, 172–182.10.17221/64/2010-VETMED]Search in Google Scholar
[Essenmacher, A. C., Nash, E., Walker, S. K., Pitcher, G. J., Buresh, C. T., Sato, T. S. (2018). Stump appendicitis. Clin. Pract. Cases Emerg. Med.,2 (3), 211–214.10.5811/cpcem.2018.3.37730607548030083635]Search in Google Scholar
[Feng, Y., Bakker, R. T., van Hest, R. M., Hodiamont, C. J., Brul, S., Schultsz, C., ter Kuile, B. H. (2017). Optimization of therapy against Pseudomonas aeruginosa with ceftazidime and meropenem using chemostats as model for infections, FEMS Microbiol. Lett., 364 (14), fnx142.10.1093/femsle/fnx142]Search in Google Scholar
[Fisher, J. F., Mobashery, S. (2014). The sentinel role of peptidoglycan recycling in the β-lactam resistance of the Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa. Bioorg. Chem., 56, 41–48.10.1016/j.bioorg.2014.05.011416164424955547]Search in Google Scholar
[Gebbers, J. O., Laissue, J. A. (2004). Bacterial translocation in the normal human appendix parallels the development of the local immune system. Ann. NY Acad. Sci.,1029, 337–343.10.1196/annals.1309.01515681775]Search in Google Scholar
[Gracia, J., Gruenberg, K., Nguyen, L., MacDougall, C. (2018). Multidrug-resistant Pseudomonas aeruginosa Iinfections: Hard to treat, but hope on the horizon? Contagion Live – Infectious Diseases Today, received from ContagionLive, Database on the World Wide Web. https://www.contagionlive.com/publications/contagion/2018/february/multidrugresistant-pseudomonas-aeruginosa-infections-hard-to-treat-but-hope-on-the-horizon (accessed 10 December 2019).]Search in Google Scholar
[Guillet-Caruba, C., Cheikhelard, A., Guillet, M., Bille, E., Descamps, P., Yin, L., Khen-Dunlop, N., Zahar, J. R., Sarnacki, S., Revillon, Y., Berche, P., Ferroni, A. (2011). Bacteriologic epidemiology and empirical treatment of pediatric complicated appendicitis. Diagn. Microbiol. Infect. Dis., 69 (4), 376–381.10.1016/j.diagmicrobio.2010.11.00321396532]Search in Google Scholar
[Guinane, C. M., Tadrous, A., Fouhy, F., Ryan, C. A., Dempsey, E. M., Murphy, B., Andrews, E., Cotter, P. D., Stanton, C., Ross, R. P. (2013). Microbial composition of human appendices from patients following appendectomy. MBio., 4 (1), e00366-12.10.1128/mBio.00366-12355154523322636]Search in Google Scholar
[Jackson, H. T., Mongodin, E. F (2014). Culture-independent evaluation of appendix and rectum microbiomes in children with and without appendicitis. PLOS One, 9 (4), 1–9.10.1371/journal.pone.0095414399740524759879]Search in Google Scholar
[Kakars, M., Rekevica, A., Engelis, A., Petersons, A. (2017). An update of a single center review in the management of acute appendicitis in children. In: International Scientific Conference, 6–7 April 2017, Rīga, Latvia. Rīga Stradiņš University, Rīga, p. 59.]Search in Google Scholar
[Kos V. N., McLaughlin R. E., Gardner H. A. (2016). Elucidation of mechanisms of ceftazidime resistance among clinical isolates of Pseudomonas aeruginosa by using genomic data. Antimicrobial agents and chemotherapy, 60 (6), 3856–3861.10.1128/AAC.03113-15487935427067331]Search in Google Scholar
[Lamps, L. W. (2010). Infectious causes of appendicitis. Inf. Dis. Clin. North Amer., 24 (4), 995-1018-ix-x.10.1016/j.idc.2010.07.01220937462]Search in Google Scholar
[Loho, T., Sukartini, N., Astrawinata, D. A. W, Immanuel, S., Aulia, D., Priatni, I. (2018). In vitro antibacterial interaction of Doripenem and Amikacin against multidrug-resistant Acinetobacter baumannii, Pseudo-monas aeruginosa, and Klebsiella pneumoniae isolates. Can. J. Infect. Dis. Med. Microbiol. Article ID 1047670, 6 pages. https://doi.org/10.1155/2018/1047670.10.1155/2018/1047670605129430065794]Search in Google Scholar
[Mazuski, J. E., Gasink, L. B., Armstrong, J., Broadhurst, H., Stone, G. G., Rank, D., Llorens, L., Newell, P., Pachl, J. (2016). Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: Results from a randomized, controlled, double-blind, phase 3 program. Clin. Infect. Dis., 62 (11), 1380–1389.10.1093/cid/ciw133487228926962078]Search in Google Scholar
[Naher, H. S., Ktab, F. K. (2013). Bacterial profile associated with appendicitis. Int. Res. J. Medical Sci., Vol. 1 (2), 1–4.]Search in Google Scholar
[Noha, A. H., Amany, H. I. M., Sahar,M. A. E., Hazem, A. W. A. R. (2015). High prevalence of multidrug resistant Pseudomonas aeruginosa recovered from infected burn wounds in children. Arch. Clin. Microbiol.,4 (4), 1–7.]Search in Google Scholar
[Ny, S., Kozlov, R., Dumpis, U., Edquist, P., Gröndahl-Yli-Hannuksela, K., Kling, A. N., Lis, D. O., Lübbert, C., Pomorska-Wesołowska, M., Palagin, I., Vilde, A., Vuopio, J., Walter, J., Wisell, K.T., Tegmark, K., NoDARS ESBL-carrier working group. (2018). Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia. Eur. J. Clin. Microbiol. Infect. Dis., 37, 2347–2354.10.1007/s10096-018-3382-830338465]Search in Google Scholar
[Parthiban, N., Harish, M. (2017). A study on microbiology culture of acute appendicectomy specimen and its correlation with wound infection. Int. Surg. J.,4, 2212–2215.10.18203/2349-2902.isj20172768]Search in Google Scholar
[Qin, X., Tran, B. G., Kim, M. J., Wang, L., Nguyen, D. A., Chen, Q., Song J., Laud, P. J., Stone, G. G. Chow, J. W. (2017). A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia. Int. J. Antimicrob. Agents, 49 (5), 579–588.10.1016/j.ijantimicag.2017.01.01028363526]Search in Google Scholar
[Rhee, K. J., Jasper, P. J., Sethupathi, P., Shanmugam, M., Lanning, D., Knight, K. L. (2005). Positive selection of the peripheral B cell repertoire in gut-associated lymphoid tissues. J. Exp. Med.,201 (1), 55–62.10.1084/jem.20041849221277015623575]Search in Google Scholar
[Rickard, J. (2018). Antibiotic use and antimicrobial resistance of surgical patients with peritonitis at a tertiary referral hospital in Rwanda. Surg. Infect.,19 (4), 382–387.10.1089/sur.2017.15829621001]Search in Google Scholar
[Roberts, J. P. (1988). Quantitative bacterial flora of acute appendicitis. Arch. Dis. Childhood, 63 (5), 536.10.1136/adc.63.5.53617789003389871]Search in Google Scholar
[Rogers, M. B., Brower-Sinning, R., Firek, B., Zhong, D., Morowitz, M. J. (2016). Acute appendicitis in children is associated with a local expansion of fusobacteria. Clin. Infect. Dis., 63 (1), 71–78.10.1093/cid/ciw20827056397]Search in Google Scholar
[Salö, M., Marungruang, N., Roth, B., Sundberg, T., Stenström, P., Arnbjörnsson, E., Fåk, F., Ohlsson, B. (2017). Evaluation of the microbiome in children’s appendicitis. Int. J. Colorectal Dis., 32 (1), 19–28.10.1007/s00384-016-2639-x521988327613729]Search in Google Scholar
[Schulin, S., Schlichting, N., Blod, C., Opitz, S., Suttkus, A., Stingu, C. S., Barry, K., Lacher, M., Bühligen, U., Mayer, S. (2017). The intra- and extraluminal appendiceal microbiome in pediatric patients. Medicine, 96, 52(e9518).10.1097/MD.0000000000009518639314829384958]Search in Google Scholar
[Snyder, M. J., Guthrie, M., Cagle, S. (2018). Acute appendicitis: Efficient diagnosis and management. Amer. Fam. Physician,98 (1), 25–33.]Search in Google Scholar
[Solomkin, J., Hershberger, E., Miller, B., Popejoy, M.., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan,G., Barie, P. S., Eckmann, C. (2015). Ceftolozane/tazobactam plus metronidazole for complicated intra-abdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI). Clin. Infect. Dis., 60 (10), 1462–1471.10.1093/cid/civ097441219125670823]Search in Google Scholar
[Terentjeva, M., Streikiša, M., Avsejenko, J., Trofimova, J., Kovaļenko, K., Elferts, D., Bērziņš, A. (2019). Prevalence and antimicrobial resistance of Escherichia coli, Enterococcus spp. and the major foodborne pathogens in calves in Latvia. Foodborne Pathog. Dis., 16 (1), 35–41.10.1089/fpd.2018.2523]Search in Google Scholar
[Turel, O. Mirapoglu, S. Y., Yuksel, M., Ceylan, A., Gultepe, B. S. (2018). Perforated appendicitis in children: Antimicrobial susceptibility and antimicrobial stewardship. J. Global Antimicrob. Resist.,16, 159–161.10.1016/j.jgar.2018.09.015]Search in Google Scholar
[Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., Darouiche, R. O. (2015). Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary tract infections, including pyelonephritis: A randomised, double-blind, phase 3 trial (ASPECT-cUTI). The Lancet, 385 (9981), 1949–1956.10.1016/S0140-6736(14)62220-0]Search in Google Scholar
[Xipell, M., Bodro, M., Marco, F., Losno, R. A., Cardozo, C., Soriano, A. (2017). Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa. Int. J. Antimicrob. Agents, 49 (2), 266–268.10.1016/j.ijantimicag.2016.11.00527979500]Search in Google Scholar
[Zhong, D., Brower-Sinning, R., Firek,B., Morowitz, M. J. (2014). Acute appendicitis in children is associated with an abundance of bacteria from the phylum Fusobacteria. J. Pediatr. Surg.,49 (3), 441–446.10.1016/j.jpedsurg.2013.06.02624650474]Search in Google Scholar